Literature DB >> 8057449

Induction in vitro of primary cytotoxic T-lymphocyte responses with DNA encoding herpes simplex virus proteins.

R J Rouse1, S K Nair, S L Lydy, J C Bowen, B T Rouse.   

Abstract

Vaccines which successfully protect against virus infections usually need to induce a broadly reactive immune response which includes the induction of cytotoxic T lymphocytes (CTL). In this study, we have used a convenient in vitro approach to investigate if plasmid DNAs encoding proteins of herpes simplex virus (HSV) are capable of inducing primary CD8+ CTL. Dendritic cells or macrophages were transfected with either plasmid DNA encoding glycoprotein B or DNA encoding the immediate-early protein ICP27. These antigen-presenting cells (APC) were then used to stimulate enriched populations of naive T cells in microcultures for 5 days in vitro. Antigen-specific CD8+ CTL which reacted both with specific protein-expressing targets and with syngeneic targets infected with HSV could be demonstrated. Dendritic cells, as APC, generated the maximal responses, but such cells needed to be transfected with DNA in the presence of a cationic lipid. However, macrophages could act as APC when they were exposed to purified DNA. HSV-primed splenocytes were also shown to generate specific CTL responses when they were stimulated with purified DNA encoding ICP27. The novel approach described in this paper promises to be extremely useful, since defining immunogenicity profiles and identifying epitopes on viral proteins should be easier and more convenient when working with DNA and investigating variables in vitro. This is particularly the case with complex viruses such as HSV, most of whose encoded proteins have yet to be isolated in sufficient quantity or purity to perform in vivo immunological studies.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8057449      PMCID: PMC236970     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  23 in total

1.  Mechanisms of induction of primary virus-specific cytotoxic T lymphocyte responses.

Authors:  M L De Bruijn; J D Nieland; T N Schumacher; H L Ploegh; W M Kast; C J Melief
Journal:  Eur J Immunol       Date:  1992-11       Impact factor: 5.532

Review 2.  The role of T cell immunity in control of herpes simplex virus.

Authors:  D S Schmid; B T Rouse
Journal:  Curr Top Microbiol Immunol       Date:  1992       Impact factor: 4.291

3.  Systemic gene expression after intravenous DNA delivery into adult mice.

Authors:  N Zhu; D Liggitt; Y Liu; R Debs
Journal:  Science       Date:  1993-07-09       Impact factor: 47.728

4.  Phagocytic processing of bacterial antigens for class I MHC presentation to T cells.

Authors:  J D Pfeifer; M J Wick; R L Roberts; K Findlay; S J Normark; C V Harding
Journal:  Nature       Date:  1993-01-28       Impact factor: 49.962

Review 5.  Antigen-presenting cell types.

Authors:  S C Knight; A J Stagg
Journal:  Curr Opin Immunol       Date:  1993-06       Impact factor: 7.486

6.  Gene inoculation generates immune responses against human immunodeficiency virus type 1.

Authors:  B Wang; K E Ugen; V Srikantan; M G Agadjanyan; K Dang; Y Refaeli; A I Sato; J Boyer; W V Williams; D B Weiner
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

7.  Heterologous protection against influenza by injection of DNA encoding a viral protein.

Authors:  J B Ulmer; J J Donnelly; S E Parker; G H Rhodes; P L Felgner; V J Dwarki; S H Gromkowski; R R Deck; C M DeWitt; A Friedman
Journal:  Science       Date:  1993-03-19       Impact factor: 47.728

8.  DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations.

Authors:  E F Fynan; R G Webster; D H Fuller; J R Haynes; J C Santoro; H L Robinson
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-15       Impact factor: 11.205

9.  Induction of primary, antiviral cytotoxic, and proliferative responses with antigens administered via dendritic cells.

Authors:  S Nair; J S Babu; R G Dunham; P Kanda; R L Burke; B T Rouse
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

10.  Downregulation of the antigen presenting cell function(s) of pulmonary dendritic cells in vivo by resident alveolar macrophages.

Authors:  P G Holt; J Oliver; N Bilyk; C McMenamin; P G McMenamin; G Kraal; T Thepen
Journal:  J Exp Med       Date:  1993-02-01       Impact factor: 14.307

View more
  9 in total

Review 1.  Type I interferons and herpes simplex virus infection: a naked DNA approach as a therapeutic option?

Authors:  S Noisakran; D J Carr
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

2.  DNA immunization of neonates induces immunity despite the presence of maternal antibody.

Authors:  E Manickan; Z Yu; B T Rouse
Journal:  J Clin Invest       Date:  1997-11-01       Impact factor: 14.808

Review 3.  Role of dendritic cells in immunopathogenesis of human immunodeficiency virus infection.

Authors:  D Weissman; A S Fauci
Journal:  Clin Microbiol Rev       Date:  1997-04       Impact factor: 26.132

4.  Immunogenicity of a bovine herpesvirus 1 glycoprotein D DNA vaccine complexed with bovine neutrophil beta-defensin 3.

Authors:  Sarah Mackenzie-Dyck; Laura Latimer; Ethel Atanley; Jennifer Kovacs-Nolan; Sam Attah-Poku; Lorne A Babiuk; Sylvia van Drunen Littel-van den Hurk
Journal:  Clin Vaccine Immunol       Date:  2014-11-05

5.  DNA immunization against herpes simplex virus: enhanced efficacy using a Sindbis virus-based vector.

Authors:  M J Hariharan; D A Driver; K Townsend; D Brumm; J M Polo; B A Belli; D J Catton; D Hsu; D Mittelstaedt; J E McCormack; L Karavodin; T W Dubensky; S M Chang; T A Banks
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

Review 6.  DNA vaccines for emerging infectious diseases: what if?

Authors:  R G Whalen
Journal:  Emerg Infect Dis       Date:  1996 Jul-Sep       Impact factor: 6.883

Review 7.  Prophylactic vaccine strategies and the potential of therapeutic vaccines against herpes simplex virus.

Authors:  Michael W Ferenczy
Journal:  Curr Pharm Des       Date:  2007       Impact factor: 3.116

8.  Bone marrow-generated dendritic cells pulsed with a class I-restricted peptide are potent inducers of cytotoxic T lymphocytes.

Authors:  A Porgador; E Gilboa
Journal:  J Exp Med       Date:  1995-07-01       Impact factor: 14.307

9.  Dendritic cells: In the forefront of immunopathogenesis and vaccine development - A review.

Authors:  Mansour Mohamadzadeh; Ronald Luftig
Journal:  J Immune Based Ther Vaccines       Date:  2004-01-13
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.